Blog
3 Things Retirees Should Know About Medicare Open Enrollment Before It Begins
Healthcare is a major expense for retirees, including those whose health is great. That's why it's important to make the most of Medicare open enrollment, which is only a little more than a week
1 Growth Stock Down 69% to Buy Right Now
Dollar General (NYSE: DG) is one of the most important retailers in the country.
The discount chain can be found in rural communities and other underserved markets, meaning it fills a unique need
Where Will Cava Stock Be in 5 Years?
Cava Group (NYSE: CAVA) shareholders are sitting fat and happy after the last year. As of this writing the stock in the Mediterranean restaurant chain is up a whopping 300% in the last 12 months
1 Magnificent S&P 500 Dividend Stock Up 3% to Buy and Hold Forever
The rallying market has lifted the valuation of dividend stocks in 2024 while simultaneously lowering their yields. Those trends have made it harder for income investors to find attractive values
The Ultimate Growth Stock to Buy With $1,000 Right Now
Warren Buffett is known for allocating capital with a value-focused mindset. This strategy has worked well for the great investor over the past few decades.
However, it seems like a lot of investors
The S&P 500 Just Did This for the First Time in 27 Years. Here's What History Says Happens Next.
The S&P 500 (SNPINDEX: ^GSPC) is the most widely followed benchmark of the stock market in the U.S., encompassing the 500 largest companies in the country. Thanks to its broad base of component
2 High-Yield Dividend Stocks Set to Soar
"The true investor... will do better if he forgets about the stock market and pays attention to his dividend returns and to the operation results of his companies." – Benjamin Graham
Taking that
I Know I'll Get Social Security in Retirement. Here's Why I'm Leaving It Out of My Plans
Retirement is still several decades away for me, but planning for it has been a top priority of mine since I entered the workforce. I've done my best to save diligently and choose the right accounts
3 Top Utility Stocks to Buy in October
Normally, utility stocks aren't very exciting. But, after a magnificent 35% rally over the past year, well, the utility sector is no doubt exciting right now. In fact, some investors might be
1 Wall Street Analyst Thinks Tesla Stock Is Going to $310. Is It a Buy?
Anticipation is building for Tesla's (NASDAQ: TSLA) upcoming "We, Robot" event on Oct. 10. Investors are expecting to hear from CEO Elon Musk about the next stage of growth for the electric vehicle
Down 45% in 6 Months, Is Dollar General Stock Too Cheap to Pass Up?
Buying a struggling stock while it's cheap can feel like you're getting a good deal, but you also need to consider the reasons behind any sell-off. If there are fundamental problems with the
Want the Max $4,873 Social Security Benefit? Here's the Salary You Need.
Social Security was never intended to provide all of anyone's retirement income, but that doesn't mean you shouldn't get the most you can out of the entitlement program. The question is, how? Your
Is Apple a Buy, Sell, or Hold in 2025?
Investors have a lot to celebrate this year, with the S&P 500 gaining 20%. While it's nice to receive high returns, it's also a good time to examine your holdings heading into the new year.
Apple's
Coca-Cola and These 2 Red-Hot Dow Dividend Stocks Are Up 10% to 22% in 3 Months, and They Could Still Be Worth Buying in October
In the beginning of 2024, the broader indexes were being driven higher mostly by mega-cap growth stocks. But the market's leadership has changed in recent months, with stodgy blue chip dividend and
Great News for EVGO Stock Investors!
The charging company got an injection of capital to help its survival prospects. Parkev Tatevosian, CFA®, discusses what the news could mean for EVGO (NASDAQ: EVGO) stock investors.
*Stock prices
My Shocking Palantir Stock Price Estimate
Palantir (NYSE: PLTR) is one of the most popular artificial intelligence (AI) stocks in the market. In this video, Parkev Tatevosian, CFA®, conducts a discounted cash flow valuation of Palantir
You Won't Believe What Nvidia CEO Jensen Huang Just Said!
The Nvidia (NASDAQ: NVDA) CEO said demand for its latest technology is insane. Parkev Tatevosian, CFA®, discusses what these comments could mean for Nvidia stock investors.
*Stock prices used were
Should You Buy Nike Stock on the Dip?
Nike (NYSE: NKE) told investors that things would get worse before they get better. In this video, Parkev Tatevosian, CFA®, answers whether investors should consider buying the stock while it's
How Much Is Amazon Stock Really Worth?
Parkev Tatevosia, CFA®, conducts a discounted cash flow valuation of Amazon (NASDAQ: AMZN) stock in this video.
*Stock prices used were the afternoon prices of Oct. 2, 2024. The video was published
Tesla Stock: Buy, Sell, or Hold?
If you believe Elon Musk, Tesla (NASDAQ: TSLA) is not an automaker anymore, it's an artificial intelligence (AI) and robotics company. That makes it much harder to assess the potential and value of
Better Artificial Intelligence Stock: BigBear.ai Vs. SoundHound AI
Breakthroughs in artificial intelligence (AI) technology are transforming various industries. Innovations from mega-cap tech leaders like Nvidia have opened the door for emerging companies to
Social Security COLAs Have Lifted Benefits 84% Over the Last Quarter Century. Is That Enough?
Social Security benefits increase annually thanks to a cost-of-living-adjustment (COLA) that is intended to help benefits rise along with inflation. However, a common perception is that COLAs have
Ford's Small EV Move Could Pay Off Big
Here's what we know, or mostly know for sure: At some point, electric vehicle (EV) sales in the U.S. market will gain serious momentum. So far, sales have chugged along more slowly than anticipated
Is Summit Therapeutics a Millionaire Maker?
The pharmaceutical industry is often about hitting home runs. Big pharmaceutical companies start small, and then a blockbuster product catapults them into the spotlight. Summit Therapeutics (NASDAQ:
Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock?
Billionaire investor Larry Robbins of hedge fund Glenview Capital Management has taken a large stake in healthcare company CVS Health (NYSE: CVS) and has met with management on ways to help turn


